Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMYLOID CARDIOMYOPATHY, TRANSTHYRETIN-RELATED
|
1 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
Anemia
|
94 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
Bone marrow hypocellularity
|
5 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
Dystransthyretinemic Euthyroidal Hyperthyroxinemia
|
4 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
Pancytopenia
|
15 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
Pneumonia
|
33 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
Transthyretin related familial amyloid cardiomyopathy
|
1 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.700 | 0 | |||||||
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
|
68 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.860 | 1.000 | 44 | 1986 | 2019 | ||||
Sessile Serrated Adenoma/Polyp
|
6 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.010 | 1.000 | 1 | 1990 | 1990 | ||||
Senile cardiac amyloidosis
|
19 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.100 | 1.000 | 14 | 1997 | 2019 | ||||
Inclusion Body Myopathy, Sporadic
|
5 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||
Amyloidosis
|
93 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.100 | 1.000 | 12 | 2001 | 2019 | ||||
Cardiomyopathies
|
294 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.780 | 1.000 | 8 | 2001 | 2019 | ||||
Familial (FPAH)
|
276 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||
Inclusion Body Myositis (disorder)
|
1 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||
Heart Diseases
|
45 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.020 | 1.000 | 2 | 2007 | 2017 | ||||
Hereditary cardiac amyloidosis
|
1 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.020 | 1.000 | 2 | 2008 | 2017 | ||||
Primary amyloidosis
|
11 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Congestive heart failure
|
165 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.070 | 0.857 | 7 | 2010 | 2019 | ||||
Arteriosclerosis
|
267 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||
Reactive systemic amyloidosis
|
11 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Heart failure
|
201 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.060 | 0.833 | 6 | 2012 | 2019 | ||||
Transthyretin cardiac amyloidosis
|
2 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.040 | 1.000 | 4 | 2012 | 2017 | ||||
Peripheral Nervous System Diseases
|
69 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Peripheral Neuropathy
|
81 | 0.653 | 0.560 | 18 | 31598655 | missense variant | G/A | snv | 1.1E-03 | 4.9E-03 | 0.020 | 1.000 | 2 | 2012 | 2015 |